Gals Bio

Pioneering Fem-Wearables for women's health and wellness, leveraging menstrual fluid for diagnostic samples and health monitoring.

Health Tech & Life Sciences
Active
Pre-Seed Mevaseret Zion, Israel Founded 2016
Last updated 2026-07-20
Total raised
$1.5M
Last: Undisclosed Round 2022-01
Stage
Pre-Seed
Founded
2016
Headcount
8
HQ
Mevaseret Zion, Israel
Sector
Health Tech & Life Sciences

About

Gals Bio is an Israeli femtech startup founded in 2016 by Hilla Shaviv. The company is focused on developing a new branch in women's health by leveraging menstrual fluid as a diagnostic sample, tested for various biomarkers. Their flagship product, Tulipon, is a novel period product that functions like a menstrual cup but with added features for health tracking and eco-friendliness. It aims to provide personalized, early, and accessible home health solutions for rapid screening, monitoring, and therapeutic care for women's health needs. Gals Bio's R&D facilities, including a class 8 regulated clean assembly room, are based in Haifa.

Funding history · 2 rounds · $1.5M total

2021-12
Seed Undisclosed
★ PipelBiz
2016-03
Pre-Seed $1.5M
★ AH trust

Headcount over time

From 8 (2020-06) to 7 (2025-12) · -1 (-12%) · 9 points · source: Finder history + radar grounding
80 2020-06 2025-12

Q&A

What is Gals Bio's primary focus?
Gals Bio is pioneering Fem-Wearables, a new category in women’s health and wellness, providing personalized, early, and accessible home health solutions through AI-powered analysis of the vaginal environment.
What is Tulipon and its purpose?
Tulipon is Gals Bio's first device, designed for the clean collection of vaginal secretions for cancer screening. It uses a liquid-lock mechanism to preserve samples for AI-powered liquid biopsy analysis, aiming for early detection and proactive reproductive health diagnostics.
When was Gals Bio founded?
Gals Bio was founded in October 2015.
What is the total amount of funding Gals Bio has raised to date?
Gals Bio has raised a total of $1,963,000 USD.
When was Gals Bio's most recent funding round and who invested?
Gals Bio's most recent funding round occurred in January 2022, with investment from PipelBiz.
Who is the Founder and CEO of Gals Bio?
Hilla Shaviv is the Founder & CEO of Gals Bio.
What is Gals Bio's primary sector?
Gals Bio's primary sector is Health Tech & Life Sciences.
What is the product stage of Gals Bio's offerings?
Gals Bio's product is currently in the clinical trial stage.

Team · 1

Hilla Shaviv
Founder · Founder & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
Materials & SubstancesPolymersSensing
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2CB2CB2B

Highlights

1 PatentsVerified

Tags

wellnessmedical-technologiesbiomarkersmedical-devicesnon-invasivemedicationmonitoringbiodegradablemedical-productswomendata-analyticsmobile-applicationssensorswomen-healthdigital-healthcarelifestylediagnosticshome-carehygienemhealthcancerblood-testwearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitetulipon.com
LinkedInlinkedin.com/company/68690050
Facebookfacebook.com/Galsbio2021

Identifiers & details

Founded2016
Employees (exact)8

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domaintulipon.com

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515328441
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2015-10-21
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressחבצלת 22 מבשרת ציון